Max Health is pleased to announce a resolution to the recent issues with Prochlorperazine 3mg buccal tablets. Max Health Director David Pascoe, said, “in order to address the needs of the New Zealand market, we have partnered with UK company Brown and Burk to achieve Medsafe registration of Prochlorperazine 3mg buccal tablets and ongoing supply for our local market.”
Prochlorperazine is indicated for a variety of conditions including:
-
the symptomatic treatment of vertigo due to Meniere’s Disease, Labyrinthitis and other causes
-
nausea and vomiting from whatever cause and
-
in the treatment of migraine1.
Max Health’s prochlorperazine 3mg buccal tablets are now:
-
Medsafe registered and
-
listed on the pharmaceutical schedule*.
*A part-charge will apply
1. Prochlorperazine data sheet, December 2024, www.medsafe.govt.nz
Prochlorperazine maleate 3mg buccal tablets.
Indications: Prochlorperazine maleate is indicated in adults & children >12 yrs: Symptomatic treatment of vertigo due to Meniere’s Disease, Labyrinthitis and other causes; For nausea and vomiting from whatever cause; In the treatment of migraine.
Warnings & Precautions: Use with caution in patients with stroke risk factors; myasthenia gravis; AIDS; hypotension; dementia; neuroleptic malignant syndrome; venous thromboembolism; QT prolongation & carbohydrate malabsorption disorders.
Interactions: Alcohol, CNS depressants; antihypertensives; neuroleptics; anticoagulants; Anticonvulsants; lithium; desferrioxamine; levodopa; anti-arrhythmics, antidepressants, macrolide-antibiotics & other antipsychotics.
Prochlorperazine maleate is a partially funded prescription only medicine. Please review the full Data Sheet before prescribing. Data sheets are available at www.medsafe.govt.nz .
Distributed by Max Health Ltd, Auckland. Date of Preparation March 2025. MXH/NZ/PROCHLORPERAZINE/002.
Max Health and Orion Pharma are proud to announce the launch of STALEVO® (levodopa, carbidopa and entacapone) tablets in New Zealand. Stalevo is a pioneering triple therapy for Parkinson’s and is fully funded from 1 February 2025.
STALEVO combines levodopa, carbidopa, and entacapone in a single tablet, providing a convenient solution for patients not stabilised on traditional levodopa/dopa decarboxylase inhibitor treatment.
Stalevo details are as follows:
Stalevo levodopa/carbidopa/entacapone OneLink Code Pharmacode
Stalevo 50/12.5/200 1260191 2696533
Stalevo 100/25/200 1260192 2696541
Stalevo 150/37.5/200 1260193 2696568
Stalevo 200/50/200 1260194 2696576
As with all other Max Health products, Stalevo Tablets can be ordered from Onelink using this contact information.
Phone: 0800-70-80-60
Fax: 0800-26-69-60
Email: customerservices@onelink.co.nz
Max Health is delighted to announce the launch of Modafinil Tablets in New Zealand. Modafinil 100mg Tablets are available now and will be listed in Section B and H of the PHARMAC Schedule effective from 1st December 2024, with Principal Supply Status commencing on 1st May 2025.
In addition to this we’d like to draw your attention to new prescribing criteria for Modafinil announced today by PHARMAC. From 1 December 2024, the renewal criteria will be removed from Modafinil tablets, making it easier for people who need this treatment to access it.
So, this is good news on two fronts for patients receiving Modafinil treatment!
Max Health Modafinil 100mg Tablet details are as follows:
Name: Modafinil Tab
Strength: 100mg; 30 tablet blister pack
OneLink Code: 1194157
Pharmacode: 2690586
Price: POA
As with all other Max Health products, Modafinil 100mg Tablets can be ordered from Onelink via the following details.
Phone: 0800-70-80-60
Fax: 0800-26-69-60
Email: customerservices@onelink.co.nz
Max Health’s Levocarnitine 500mg capsules are available and listed in the Pharmaceutical Schedule from Sept 1st 2024
Metabolics-brand Levocarnitine capsules are Australian made in a GMP accredited manufacturing facility. Capsules are 500mg each and pack (pot) contains 300 caps. Both the capsule and content is vegetarian friendly and has a low carbohydrate content so may be useful for those requiring a ketogenic diet.
Details of Levocarnitine are as follows:
Product: Metabolics Levocarnitine 500mg Capsules
Manufacturer: Reach Pharma, Australia
Pharmacode: 2683059
OneLink code 1165451
Schedule: Listed from 1st September 2024
As with all Max Health products, Metabolics-brand Levocarnitine caps are available through OneLink.
Phone: 0800 70 80 60
Fax: 0800 26 69 60
Max Health is pleased to announce the listing of Modafinil 100mg Tablets in Section B and H of the PHARMAC Schedule effective from the 1st November 2024. The product is supplied by our partner Chanelle Pharma based out of Ireland and has been awarded Principal Supply Status from the 1st May 2025.
Modafinil 100mg Tablet details are as follows:
Name: Modafinil
Strength: Tab 100mg; 30 tablet blister pack.
Pharmacode: 2690586
Price: POA
As with all other Max Health products, Modafinil 100mg Tablets can be ordered from Onelink via the following details.
Phone: 0800 70 80 60
Fax: 0800 26 69 60
Do you have a great idea for improving patient care?
-
Are you struggling to implement a new model of service due to lack of resources?
-
Got the initiative but need the support?
-
Would you like a complimentary registration to the New Zealand Hospital Pharmacy Association (NZHPA) Conference?
If the answer is yes, this grant could be for you!
Max Health, a small and innovative NZ based company, are proud to offer this $3000 prospective grant to support research and professional development in areas that align with the values of Max Health:
-
Innovation in pharmacy practice
-
Problem solving
-
Exceeding customer expectations
The grant can be used to support service improvement initiatives, research projects, national or international study tours, preceptorships, international and local travel to relevant conferences.
Submit your proposal and you could be one of the finalists invited to pitch your idea to a panel of judges via Teams in September 2024. The winner will receive a complimentary registration to the 2024 NZHPA Conference in Dunedin, 23-24 November to present their winning idea.
Eligibility criteria
-
Applications must demonstrate innovation in pharmacy practice, problem solving or exceeding customer expectations.
-
Work can be current, prospective, or retrospective work (within the last 12 months) that you wish to develop further.
-
Applicants must be current ordinary members of the New Zealand Hospital Pharmacy Association (NZHPA).
Application Process
Complete the online application form by 5pm Friday 6 September 2024 via the NZHPA Website – HERE
If you have any questions please contact Lisa, NZHPA Administrator: nzhpa@nzhpa.org.nz
Max Health is delighted to announce the listing of Nicorandil 10mg and 20mg tablets in Section B and H of the PHARMAC Schedule effective from the 1st December 2023. The product is supplied by our partner Rivopharm based out of Switzerland and has been awarded Principal Supply Status from the 1st May 2024.
Nicorandil Tablet details are as follows:
Name: Nicorandil Oral Tablets
Strength: 10mg
Pharmacode: 2669242
Name: Nicorandil Oral Tablets
Strength: 20mg
Pharmacode: 2669250
As with all other Max Health products, Nicorandil tablets can be ordered from Onelink via the following details.
Phone: 0800 70 80 60
Fax: 0800 26 69 60
Email:
Max Health is proud to be supporting the annual Max Health Pharmacy Innovation Showcase Award 2023 at the upcoming NZHPA Annual Conference held in Wellington this year.
– Do you have a great idea for improving patient care?
– Are you struggling to implement a new model of service due to lack of resources?
– Are you currently running something that needs a boost?
– Got the initiative, but need the support?
If the answer is yes, the Max Health Pharmacy Innovation Showcase Award 2023 could be for you.
Complete an Application for Max Health Award found on the NZHPA website at http://www.nzhpa.org.nz/
Max Health are proud to offer this award to support research and professional development of clinical pharmacists and technicians in areas that align with the values of Max Health:
-
Innovation in pharmacy practice
-
Problem solving
-
Exceeding customer expectations
Max Health would like to extend a warm welcome to our newest team members, Lisa Chang and Leanne Carpendale.
LISA CHANG
Commercial Manager
Lisa joined Max Health in September 2022 after gaining over 10 years of pharmaceutical experience since starting her career initially as a NZ registered pharmacist at various Unichem and Life Pharmacies before moving into the pharmaceutical industry whilst completing a Masters in Bioscience Enterprise. Lisa brings a wealth of international pharmaceutical experience and networks through leading market expansion of innovative medicines into more than twenty markets across Asia, Northern America, UK and Europe whilst at AFT Pharmaceuticals. This experience developed her skills across the various functions of the pharmaceutical business. Lisa joined as Commercial Manager and manages our Key Supplier Accounts, Sales and Marketing of Promoted products and the National Tender process for the company.
In her free time, you can find Lisa enjoying walks with her family or outside growing cut- flowers in her garden.
LEANNE CARPENDALE
Office Administration and Logistics Co-ordinator
Leanne joined the Max Health team at the start of 2023. She brings with her a vast array of skills, experience, and wisdom to the Max Health team. Leanne previously worked for Janssen-Cilag for 23 years in a variety of marketing and administrative roles. At Max Health, Leanne provides support for Logistics functions. She also manages the Max Health office, handling a wide range of administrative duties.
Outside of Max Health Leanne is a Mother of two Teenage boys. Leanne spends a lot of her spare time at Auckland United Football Club, where she is Youth Chair, Grade Co-ordinator and the Manager of both her son’s teams.
2023 is off to a great start with our newest additions! Welcome to the Max Health team Lisa and Leanne.
Max Health is delighted to announce clinical pharmacist Fiona McNabb as the winner of the Max Health Pharmacy Innovation Showcase Award 2022.
Fiona started Talking about Medicines as a passion project to help people better understand how and why their medicines work. Using simple drawings and a spoken ‘story’ her videos effectively communicate WHY medicines are useful for certain conditions, HOW they work and WHAT benefits you should expect to get from them. Anyone can access the Talking About Medicines videos free via the website.
With the Max Health Pharmacy Innovation Showcase Award funding, Fiona and her team are looking forward to producing te reo Māori translations of cardiac videos including ‘How the heart works.’
Max Health are proud to offer this award to support research and professional development of clinical pharmacists and technicians in areas that align with the values of Max Health:
-
Innovation in pharmacy practice
-
Problem solving
-
Exceeding customer expectations
We look forward to meeting this year’s applicants at the NZHPA Annual Conference 2023.
Max Health is pleased to announce the listing of Levomepromazine hydrochloride (Wockhardt) inj 25 mg per ml, 1 ml ampoule in Section B and H of the PHARMAC Schedule effective from the 1st November 2022. The product is supplied by our partner Wockhardt, based out of the UK and has been awarded Principal Supply Status from the 1st April 2023.
Levomepromazine Injection details are as follows:
Name: Levomepromazine hydrochloride injection
Strength: 25mg/1mL, 10 x 1mL ampoules
Onelink Code: PHAE76
Pharmacode: 2501902
Price: POA
As with all other Max Health products, Levomepromazine injection can be ordered from Onelink via the following details.
Phone: 0800 70 80 60
Fax: 0800 26 69 60
Max Health is pleased to announce the upcoming launch of Clindamycin-hameln, 150mg/mL solution for injection, the newest addition to Hameln Pharma’s growing product portfolio in New Zealand.
Clindamycin Injection has been awarded Principal Supply Status from the 1st August 2023 and will be available in New Zealand from the 12th February 2023 from Onelink. This recent announcement is a testament to the commitment of Max Health and Hameln in serving the wellbeing of patients through supply of high quality and reliable European products in New Zealand.
Clindamycin details are as follows:
Name: Clindamycin Injection
Strength: 150mg/mL, 4mL x 10
Onelink Code: PHZB72
Pharmacode: 2646595
Price: POA
As with all other Max Health products, Clindamycin can be ordered from Onelink via the following details.
Phone: 0800 70 80 60
Fax: 0800 26 69 60
Email: customerservices@onelink.co.nz
About Hameln Plus – Germany
The Hameln group, based in Hameln Germany has over 100 years of company history behind it, having been run by the same family for four generations. It produces an outstanding range of injectable anaesthetic and intensive medicine products, in a state of the art sterile facility. Products approved and marketed in NZ include Alfentanil, Cyclizine, Dexamethasone, Amiodarone, Naloxone, Neostigmine, Oxycodone, Dobutamine, Flumazenil and Rocuronium injections.
About Max Health
Established in 2008, Max Health™ is a New Zealand founded pharmaceutical company providing products and solutions to the New Zealand health care market. We distribute a wide variety of pharmaceutical products sourced from well established European pharmaceutical companies. We pride ourselves in providing high quality products with reliable local service.
In July 2021 API Consumer Brands announced its exit from the New Zealand pharmaceutical market, thus affecting the supply of a number of important products.
Max Health has since taken over the supply for the following API products.
Name: Buccastem (Prochlorperazine Maleate) tablets
Strength: 3mg x 50
Onelink Code: PHE274
Pharmacode: 340537
Price: POA
Buccastem tablets are listed in Section B of the Pharmaceutical Schedule.
Name: Syntometrine (Oxytocin and Ergometrine) Injection
Strength: 5IU/mL oxytocin 0.5mg/mL ergometrine in 5 x 1mL ampoules
Onelink Code: 256269
Pharmacode: CSP012
Price: POA
Syntometrine injection is currently listed in both Section B and H of the Pharmaceutical Schedule and will enjoy sole supply in the latter from December 1, 2022.
These products will be supplied by our UK partner, Alliance. This partnership continues to exemplify the reliability and integrity of Alliance; Max Health looks forward to growing their portfolio in New Zealand.
The aforementioned products from Alliance are available now from OneLink, as is the rest of the extensive portfolio Max Health offers. These can be ordered from:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Hameln, once again, have proven their European products superior to many alternatives offered to the New Zealand market. Dexamethasone, supplied by Max Health’s German supplier Hameln, has been awarded in the recent tender announcement.
Being on the World Health Organisation’s List of Essential Medicines, Dexamethasone solution for injection, is relied on by a number of patients throughout the country and Max Health is proud to be able to supply a product of the highest quality to meet these needs. Manufactured in Europe in accordance with some of the highest regulatory standards in the world, Hameln’s Dexamethasone will be available in New Zealand from August 12th and will enjoy principal supply status until June 30 2025. Dexamethasone details follow.
Name: Dexamethasone Phosphate Injection
Strength: 4mg/mL, 1mL x 10
Onelink Code: PHAZ823
Pharmacode: 2451689
Price: POA
Name: Dexamethasone Phosphate Injection
Strength: 4mg/mL, 2mL x 10
Onelink Code: PHAG90
Pharmacode: 2519143
Price: POA
Max Health products can be ordered from our distributor, Onelink via the following contact details.
Phone: 0800 70 80 60
Fax: 0800 26 69 60
Over the last 130 years Hameln has grown into an international supplier of generic pharmaceuticals, specialising in injectables. It boasts an impressive history, having been bought from the inventor of morphine, Friedrich Wilhelm Adam Sertϋrner. This foundation continues to influence the focus of Hameln’s growth and its expertise in manufacturing and distributing analgesics.
Whilst Hameln is based in Germany, it has a number of offices located around the world including in Hong Kong, the Netherlands, the UK, and Australia. Hameln products are manufactured in state-of-the-art facilities to a high quality, in accordance with New Zealand and European regulatory standards. Hameln has been a trusted supplier to Max Health for a number of years and continue to provide a service from which is rooted its core values of loyalty, openness, and reliability.
Max Health is proud to be supplying Hameln products to the New Zealand market, three of which have recently been awarded in the tender. For two of these products, Cyclizine and Amiodarone Injections, the tender agreement ensures continual supply of the Hameln product already being used in the market. Both Cyclizine and Amiodarone will be listed in Sections H and B of the Pharmaceutical Schedule. The details for these products are as follows.
Name: Cyclizine Lactate Injection
Strength: 50mg/mL in 1mL x 10
Onelink Code: PHAS85
Pharmacode: 2595877
Price: POA
Name: Amiodarone Hydrochloride Injection
Strength: 50mg/mL in 3mL x 10
Onelink Code: PHAN24
Pharmacode: 2565129
Price: POA
Both Cyclizine and Amiodarone Injections will continue to enjoy principal supply status until June 30th, 2025.
Another Hameln product, Naloxone, is authorised for Denmark, Germany, Sweden, the UK and the Netherlands and is now available to the New Zealand market. Naloxone Injection will enjoy sole supply until June 30th, 2024. This will be listed in Sections H and B of the Pharmaceutical Schedule. The change in subsidy will occur on September 1st, 2022. Details for Naloxone is as follows.
Name: Naloxone Hydrochloride Injection
Strength: 400mcg/mL in 1mL x 10
Onelink Code: PHAZ58
Pharmacode: 2634090
Price: POA
All Max Health products, including those supplied by Hameln as well as other industry-leading pharmaceuticals, are distributed by Onelink. These can be ordered from:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Good afternoon,
Max Health is pleased to announce the following news regarding its partner Orion.
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion’s net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.
Company website: https://www.orion.fi/en/
Since 2020 Orion has expanded its commercial footprint to the Asia Pacific region (Malaysia, Singapore and Thailand). This year the company is establishing its own operations in New Zealand and Australia.
Max Health™ was established in 2008 and distributes a variety of pharmaceutical and medical products in New Zealand for a number of international partners. Their expertise, local knowledge and network of contacts has helped build a solid reputation for reliability and innovation in the NZ pharmaceutical sector. They have distributed a number of Orion products in NZ since their first Orion launch in 2012.
Orion has plans to invest in NZ and to offer an expanded range of products to NZ patients. While Orion has committed to establishing a NZ subsidiary, it is important to note that they have retained the services of Max Health to its represent its products to NZ customers, and to bring its products under one umbrella in this country. Max Health is delighted to be partnering with Orion in this exciting expansion of their product portfolio in NZ.
If you have any questions please feel free to contact me.
Best regards,
Patrick Forrester
Director- Max Health Ltd
Mob: 021 311 357 Ph: +64 9 815 2664
Max Health is pleased to confirm that is has been awarded the tender for all three strengths of Octreotide Injection – 50mcg/mL in 1mL; 100mcg/mL in 1mL; 500mcg/mL in 1mL. These are supplied by our Australian partner, Generic Health. Octreotide Injections will be listed in both sections H and B of the Pharmaceutical Schedule and will have Principal Supply Status until 30 June 2024.
This change in subsidy will occur on February 1st 2022.
Distribution of all Max Health products, including Octreotide Injections, are managed by Onelink. These can be ordered from:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Octreotide Injection details are as follows:
Name: Octreotide Injection
Strength: 50mcg/mL in 1mL x 5
Onelink Code: PHAX70
Price: POA
Name: Octreotide Injection
Strength: 100mcg/mL in 1mL x 5
Onelink Code: PHAX71
Price: POA
Name: Octreotide Injection
Strength: 500mcg/mL in 1mL x 5
Onelink Code: PHAX72
Price: POA
Max Health is happy to announce that is has been awarded the tender for all three presentations of Oxycodone Injection – 10mg/mL in 1mL; 10mg/mL in 2mL; 50mg/mL in 1mL. These are manufactured by our German supplier, Hameln. Oxycodone Injections will be listed in both sections H and B of the Pharmaceutical Schedule and will enjoy Principal Supply Status until 30 June 2024.
This change in subsidy will occur on February 1st 2022.
Distribution of the Oxycodone Injections range, as well as all other Max Health products, are handled by Onelink. These can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Oxycodone Injection details are as follows:
Name: Oxycodone Injection
Strength: 10mg/mL in 1mL x 5
Onelink Code: PHAZ07
Price: POA
Name: Oxycodone Injection
Strength: 10mg/mL in 2mL x 5
Onelink Code: PHAZ08
Price: POA
Name: Oxycodone Injection
Strength: 50mg/mL in 1mL x 5
Onelink Code: PHAZ09
Price: POA
Max Health is happy to report that is has been awarded the tender for Neostigmine Metisulfate injection 2.5mg/mL in 1mL. This product is manufactured by our German supplier, Hameln. Neostigmine Metisulfate will be listed in both sections H and B of the Pharmaceutical Schedule, and will enjoy Principal Supply Status until 30 June 2024.
This change in subsidy will occur on October 1st 2021.
Distribution of all Max Health products, including Neostigmine Metisulfate, will be handled by Onelink. These can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Neostigmine Metisulfate Injection details are as follows:
Name: Neostigmine Metisulfate Injection
Strength: 2.5mg/mL, 1mL amps x 10
Onelink Code: PHAT58
Pharmacode: 2599996
Price: POA
Max Health is pleased to announce that it has been awarded the tender for Flumazenil Injection 0.1mg/mL in 5mL. This product is manufactured by our long-standing German supplier, Hameln. Flumazenil will be listed in Section H of the Schedule.
This change in subsidy will occur on September 1st, 2021.
Distribution of Flumazenil Injection will be handled by Onelink along with all other Max Health products. These can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Flumazenil Injection details are as follows:
Name: Flumazenil Injection
Strength: 0.1mg/mL, 5mL amps x 10
OneLink Code: PHAL99
Pharmacode: 2558904
Price: POA
Max Health is happy to announce that it has been awarded the tender for Dopamine Hydrochloride 200mg/5mL. This injection is manufactured by Martindale. Dopamine will be listed in Section H of the Schedule.
This change in subsidy will occur on November 1st, 2021.
Distribution of Dopamine Hydrochloride Injection will be handled by Onelink, as are all Max Health products. All Max Health products can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Dopamine Hydrochloride Injection details are as follows:
Name: Dopamine Hydrochloride
Strength: 40mg/mL, 5mL x 10
OneLink Code: PHY722
Pharmacode: 2374374
Price: POA
Max Health is pleased to announce that it has been awarded the tender for Atropine Sulphate 600mcg/mL. This product is manufactured by Martindale, based out of the UK. Atropine Sulphate will be listed in Section H and Section B of the Schedule.
Max Health will commence with this change in subsidy on August 1 2021.
Distribution of Atropine Sulphate will be handled by Onelink, as are all other Max Health products. Max Health products can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Atropine Sulphate injection details are as follows:
Name: Atropine Sulphate
Strength: 600mcg/1 mL
Onelink Code: PHAI22
Pharmacode: 2528754
Price: POA
Max Health is pleased to announce that it has received approval from Medsafe for the registration of Ethinylestradiol 30mcg and Levonorgestrel 150mcg (branded as Lynley™) oral contraceptive for use in New Zealand. This registration is effective from 11 March 2021.
This product is part of a collaboration with our Australian partner, Generic Health, and is manufactured by leading international generic pharmaceutical company, Lupin. We await a decision from PHARMAC regarding potential reimbursement of the product.
Max Health is pleased to have been awarded the tender for Glycopyrronium Bromide 0.5mg/mL with Neostigmine Metisulfate 2.5mg/mL Injection. This product is manufactured by Martindale in the UK. It will be listed in Section H of the Schedule.
Distribution of Glycopyrronium Bromide Neostigmine Metisulfate injection will be handled by Onelink, as is all Max Health products. These can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Glycopyrronium Bromide Neostigmine injection details are as follows:
Name: Glycopyrronium Bromide Neostigmine
Strength: Glycopyrronium Bromide 0.5mg/mL with Neostigmine Metisulfate 2.5mg/mL, 1mL ampoules x 10
Onelink Code: PHZ004
Pharmacode: 1111133
Price: POA
Max Health is excited to announce that it has been awarded the tender for Dobutamine 12.5mg/mL. This product is manufactured in Germany by its trusted partner, Hameln. Dobutamine will be listed in Section H of the Schedule.
Distribution of Dobutamine, as well as all other Max Health products, continues to be handled by Onelink. Max Health products can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Dobutamine injection details are as follows:
Name: Dobutamine
Strength: 12.5 mg/1 mL
Onelink Code: PHZ805
Pharmacode: 1123349
Price: POA
Max Health is delighted to announce that it has received approval from Medsafe regarding the registration of Variquel (Terlipressin) 0.2mg/mL in 5mL solution for Injection for use in New Zealand. This is effective 28 January 2021.
This product is manufactured in Europe and is supplied to Max Health by Alliance.
Max Health is pleased to have received advice from Medsafe, that effective 01/10/2020 Naltrexone 50mg tablets are registered for use in New Zealand. This product is manufactured in Europe and is supplied to Max Health by our Australian partner by Generic Health.
Max Health™ is delighted to announce that it has been awarded the Tender for Magnesium Sulfate 2 mMol /1 mL. Martindale supplies Magnesium Sulfate to Max Health. This product will be available to order from 12 January 2021. Magnesium Sulfate will be listed in both Sections B and H of the Schedule.
Distribution of Magnesium Sulfate, and all other Max Health™ products, continues to be handled by Onelink. Magnesium Sulfate injection can be ordered from:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Magnesium Sulfate injection details are as follows:
Name: Magnesium Sulfate
Strength: 2 mMol/1 mL
Onelink Code: PHZ354
Pharmacode: 2406438
Price: POA
Max Health™ is happy to announce that it has been awarded the Tender for Cyclizine Lactate 50 mg/1 mL. Cyclizine Lactate is manufactured by Hameln Pharma in Germany. This will be available to purchase from 12 November 2020; cyclizine Lactate will be listed in Section B of the Schedule.
Distribution and ordering of Cyclizine Lactate injection, and all other Max Health™ products, are handled by Onelink. Cyclizine Lactate injection can be ordered from:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Cyclizine Lactate injection details are as follows:
Name: Cyclizine Lactate
Strength: 50 mg/1 mL
Onelink Code: PHAS85
Pharmacode:
Price: POA
Max Health™ is pleased to announce that it has been granted the Tender for Alfentanil 0.5 mg/1 mL. Alfentanil is manufactured Germany by Hameln Pharma and will be available to buy from 12 July 2020. Alfentanil will be listed in Section H of the Schedule.
Distribution of all Max Health™ products, including Alfentanil, continues to be handled by Onelink. Alfentanil injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Alfentanil injection details are as follows:
Name: Alfentanil
Strength: 0.5 mg/1 mL
Onelink Code: PHAA21
Pharmacode: 2468417
Price: POA
Max Health™ is happy to announce that it has been given the Tender for Metaraminol 10 mg/1 mL. This product is manufactured and supplied to Max Health by Torbay Pharmaceuticals. It will be available from 12 July 2020 and listed in Section H of the Schedule.
Distribution of Metaraminol injection will be handled by Onelink. Metaraminol injection, as well as all other Max Health™ products can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Metaraminol injection details are as follows:
Name: Metaraminol
Strength: 10 mg/1 mL
Onelink Code: PHAC49
Pharmacode: 2482983
Price: POA
Max Health™ is delighted to announce that it has been awarded the Tender for Clarithromycin 500 mg single vials. Manufactured by Martindale Pharma in the UK, Clarithromycin will be available to purchase from 12 August 2020. It will be listed in Section H of the Schedule.
Distribution of Clarithromycin vials, and all other Max Health™ products, continues to be handled by Onelink. All Max Health™ products can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Clarithromycin details are as follows:
Name: Clarithromycin
Strength: 500 mg single vials
Onelink Code: PHAA71
Pharmacode: 2470969
Price: POA
Max Health™ is happy to announce that it has been awarded the Tender for Suxamethonium Chloride 50 mg/1 mL. This product is manufactured by Martindale Pharma in the UK and will be available to purchase from 12 August 2020. Suxamethonium Chloride will be listed in Section H of the Schedule.
Distribution of Suxamethonium Chloride will be be handled by Onelink. Suxamethonium Chloride Injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Suxamethonium Chloride injection details are as follows:
Name: Suxamethonium Chloride
Strength: 50 mg / 1 mL
Onelink Code: PHZ669
Pharmacode: 2442205
Price: POA
Max Health is happy to have been informed by Medsafe that as of 09/04/2020 Oxycodone 50mg/mL and Oxycodone 10mg/mL solutions for injection are registered for use in New Zealand. This product is manufactured in Europe and is supplied to Max Health by its long-standing German supplier, Hameln Pharma.
Max Health™ is pleased to announce that it has been awarded the Tender for Ephedrine 30 mg/1 mL. This is manufactured by Martindale Pharma in the UK and will be available to order from 12 June 2020. Ephedrine will be listed in Section H of the Schedule.
Distribution of Ephedrine, as well as all other Max Health™ products continues to be handled by Onelink. Orders can be made from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Ephedrine injection details are as follows:
Name: Ephedrine
Strength: 30 mg / 1 mL
Onelink Code: PHZ352
Pharmacode: 2402874
Price: POA
Max Health is happy to announce the approval of TapClob Oral suspension for registration for use in New Zealand, as advised by Medsafe. This is effective as of 27/02/2020 and applies to both concentrations of 5mg/mL and 10mg/mL. This product is manufactured in the UK. It is supplied to Max Health by Ethypharm UK.
Max Health™ is pleased to introduce the Mevalia range of low protein products to New Zealand.
Mevalia is Dr. Schär’s range of food products with low protein content, specifically formulated for the treatment of Phenylketonuria (PKU), other related disorders and for people with diets that are required to be low in protein.
The Mevalia brand is dedicated through its products and services to helping improve the lives of people with particular dietary requirements. It has been developed by Dr Schär which has been a leader in nutrition for specific needs for nearly 40 years.
With this in mind, Dr. Schär and Mevalia focus on both the quality and effectiveness of their products – supported by continuous research – and developing products that simply taste great!
Max Health™ is delighted to be associated with this exciting new range.
To order please visit www.mevalia.co.nz
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 17/10/2019 Cyclizine injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health™ by Hameln Pharma Plus.
Max Health™ is delighted to announce that it has been awarded the Tender for Rocuronium Bromide 50 mg/5 mL. Rocuronium Bromide is manufactured by Hameln Pharma in Germany and will be available to purchase from 12 March 2020. Rocuronium Bromide will be listed in Section H of the Schedule.
Distribution of Rocuronium Bromide injection, and all other Max Health™ products, continues to be is handled by Onelink. Rocuronium Bromide injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Rocuronium Bromide injection details are as follows:
Name: Rocuronium Bromide
Strength: 50 mg/5 mL
Onelink Code: PHAP99
Pharmacode: 2577143
Price: POA
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 20/6/2019 Valganciclovir 450mg tablets have been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health™ by Pharmathen.
Max Health™ is delighted to announce that it has been awarded the Tender for Amiodarone Hydrochloride 150 mg/3 mL injection. Amiodarone is manufactured by Hameln Pharma in Germany and will be available to purchase from 1 August 2019. Amiodarone will be listed in Section B and H of the Schedule.
Distribution of Amiodarone injection, and all other Max Health™ products, continues to be is handled by Onelink. Amiodarone injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Amiodarone injection details are as follows:
Max Health™ is delighted to announce that it has been awarded the Tender for Caspofungin 50mg and 70 mg infusion. Caspofungin is manufactured by Martindale Pharma in the UK and will be available to purchase from 12 June 2019. Caspofungin will be listed in Section H of the Schedule.
Distribution of Caspofungin infusion, and all other Max Health™ products, continues to be handled by Onelink. Caspofungin infusion can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Caspofungin injection details are as follows:
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 28/2/2019 Amiodarone 150mg/3ml injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health™ by Hameln Pharma Plus.
Max Health™ is delighted to announce the signing of a new distribution agreement with Alliance Pharmaceuticals Ltd, a UK based pharma company.
The first product associated with this new agreement is the local anaesthetic, Ametop Topical Gel (4% w/w Tetracaine). Ametop Gel is a fast acting, long lasting local anaesthetic formulation that is suitable for a wide patient population, including children aged from just one month.
“We are very excited about this new collaboration with Alliance Pharmaceuticals” said Max Health™ Marketing Director Patrick Forrester.
“They are a leading international healthcare business. A true alliance of people, brands and parties working together to achieve more for patients. We look forward to achieving great things in this new commercial relationship with this highly effective, firmly established, product.”
Local distribution of Ametop Gel and all other Max Health™ products continues to be handled by Onelink.
Ametop Gel can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 4 October 2018 Caspofungin 50mg and 70mg powder for infusion has been registered for use in New Zealand. This product is manufactured in the UK and supplied to Max Health™ by Martindale Pharma.
Max Health™ is delighted to announce that it has been awarded the Tender for Flumazenil injection 0.1mg/ml in 5ml from 1 October 2018. Flumazenil is manufactured by Hameln Pharma in Germany and will be available to purchase from 12 September 2018. Flumazenil will be listed in Section H of the Schedule.
Distribution of Flumazenil injection, and all other Max Health™ products, continues to be is handled by Onelink. Flumazenil injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Flumazenil injection details are as follows:
Max Health™ is delighted to announce that it has been awarded the Tender for Thiamine Hydrochloride 50mg Tablets from 1st September 2018. Thiamine Hydrochloride 50mg Tablets are manufactured by Kent Pharmaceuticals in the UK and will be listed in both Section B and Section H of the Schedule.
Distribution of Thiamine Hydrochloride 50mg Tablets, and all other Max Health™ products, continues to be is handled by Onelink. Thiamine Hydrochloride 50mg Tablets can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Thiamine Hydrochloride 50mg Tablets details are as follows:
Max Health™ is delighted to announce that it has been awarded the Tender for Dobutamine injection 250mg/20ml. Dobutamine is manufactured by Hameln Pharma in Germany and will be available to purchase from 12 October 2018. Dobutamine will be listed in Section H of the Schedule.
Distribution of Dobutamine injection, and all other Max Health™ products, continues to be is handled by Onelink. Dobutamine injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Dobutamine injection details are as follows:
Max Health™ is delighted to announce that we have been awarded the Tender for Atropine Sulfate Solution for Injection from 1 August 2018.
Atropine Sulfate Solution for Injection is manufactured by Martindale Pharma in the UK and will be listed in both Section B and Section H of the Schedule.
Distribution of Atropine Sulfate Solution for Injection, and all other Max Health™ products, continues to be is handled by Onelink. Atropine Sulfate Solution for Injection is available for sale now and can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Atropine Sulfate Solution for Injection details are as follows:
Max Health™ is delighted to announce that it has been awarded the Tender for Martindale’s Sterile Dopamine Concentrate Solution for Injection from July 1st 2018.
Distribution of Sterile Dopamine Injection, and all other Max Health™ products, continues to be is handled by Onelink. Sterile Dopamine Injection is available now and can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Sterile Dopamine Injection details are as follows:
Max Health™ is delighted to announce that it has been re-awarded Sole Supply Status for Buspirone 5mg and 10mg Tablets through to 30th June 2021. Buspirone 5mg and 10mg Tablets are manufactured by Orion Corporation in Finland for Max Health™ in NZ and are now available for purchase, and we are pleased that this commercial relationship continues to work positively for both parties.
Distribution of Buspirone 5mg and 10mg Tablets, and all other Max Health™ products, continues to be is handled by Onelink. Buspirone 5mg and 10mg Tablets can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Buspirone 5mg and 10mg Tablets details are as follows:
The directors of Max Health have recently returned from a pretty exhausting schedule at the CPhI Conference in Frankfurt. Some great meetings were had with our existing European partners, including Martindale, Hameln, Torbay and Sintetica.
We were also delighted to meet with some exciting new potential suppliers. We’re looking forward to continuing to deliver high quality, well priced products to the New Zealand Healthcare sector.
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 10/08/2017 Atropine Sulphate injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health™ by Martindale Pharma.
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 29/6/2017, Naloxone injection has been registered for use in New Zealand. This product is manufactured in Germany and supplied to Max Health™ by Hameln Plus.
Max Health™ is pleased to announce that it has been re-awarded Hospital Supply Status for Ephedrine Hydrochloride Injection. The Ephedrine Injection is manufactured by Martindale Pharma in the UK for Max Health™ in NZ. Ephedrine Injection is now available for purchase.
Distribution of Ephedrine Injection, and all other Max Health™ products, continues to be handled by Onelink. Ephedrine Injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Ephedrine Injection details are as follows:
Name: Ephedrine Hydrochloride Injection
Strength: 30mg/ml in 1ml ampoules (10 amps)
Onelink Code: PHZ352
Pharmacode: 2402874
Price: POA
Max Health™ is pleased to announce that it has been re-awarded Hospital Supply Status for Clarithromycin Injection 500mg. The Clarithromycin Powder for Injection is manufactured by Martindale Pharma in the UK for Max Health™ in NZ.
Distribution of Clarithromycin Powder for Injection, and all other Max Health™ products, is handled by Onelink. Clarithromycin Powder for Injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Clarithromycin Powder for Injection details are as follows:
Name: Clarithromycin Powder for Solution in 1ml Vials
Strength: 500mg
Onelink Code: PHAA71
Pharmacode: 2470969
Price: POA
Max Health™ is delighted to announce that it has received advice from Medsafe, that effective 20/4/2017, Apomorphine injection has been registered for use in New Zealand. This product is manufactured in Sweden and supplied to Max Health™ by PharmSwed.
Max Health™ is delighted to announce that it has been awarded Sole Supply Status for Levomepromazine injection. Levomepromazine injection is manufactured by Wockhardt Pharmaceuticals in Europe for Max Health™ in NZ. Levomepromazine injection is now available for purchase.
Distribution of Levomepromazine injection, and all other Max Health™ products, continues to be handled by Onelink. Levomepromazine injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Levomepromazine injection details are as follows:
Name: Levomepromazine Injection
Strength: 25mg/ml 1ml (pack of 10)
Onelink Code: PHAE76
Pharmacode: 2501902
Price: POA
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 21/04/2016, Baclofen injection has been registered for use in New Zealand. This product is manufactured and supplied to Max Health™ by Sintetica, a high quality partner from Switzerland.
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 7/04/2016, Zoledronic Acid injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health by Hameln Plus.
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 7/04/2016, Levomepromazine injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health by Wockhardt Pharmaceuticals.
Distribution of Levomepromazine injection, and all other Max Health™ products, continues to be handled by OneLink. Products can be ordered from OneLink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Max Health™ is pleased to announce that it has been awarded Hospital Supply Status for Milrinone Injection. The Milrinone Injection is supplied by Generic Health for Max Health™ in NZ.
Distribution of Milrinone Injection, and all other Max Health™ products, is handled by Onelink. Milrinone Injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Milrinone Injection details are as follows:
Name: Milrinone Injection
Strength: 1mg/ml in 10ml (10 amps)
Onelink Code: PHAE38
Pharmacode: 2496542
Price: POA
Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 4/2/2016, Milrinone injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health by Generic Health.
Distribution of Milrinone injection, and all other Max Health™ products, continues to be handled by OneLink. Products can be ordered from OneLink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Max Health™ is delighted to announce that it has been awarded Sole Supply Status for Buspirone 5mg and 10mg Tablets. Buspirone 5mg and 10mg Tablets are manufactured by Orion Corporation in Finland for Max Health™ in NZ and are now available for purchase.
Distribution of Buspirone 5mg and 10mg Tablets, and all other Max Health™ products, continues to be handled by Onelink. Buspirone 5mg and 10mg Tablets can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Buspirone 5mg and 10mg Tablets details are as follows:
Name: Buspirone 5mg
Strength: 5mg Tablets (pack of 100)
Onelink Code: PHAD89
Pharmacode: 2494132
Price: POA
Name: Buspirone 10mg
Strength: 10mg Tablets (pack of 100)
Onelink Code: PHAD90
Pharmacode: 2494140
Price: POA
Max Health™ is delighted to announce the advice received from Medsafe, that effective 10/12/2015, Buspirone 5mg and 10mg tablets have been registered for use in New Zealand. This product is manufactured in Finland and supplied to Max Health™ by Orion Corporation.
Distribution of Buspirone 5mg and 10mg tablets, and all other Max Health™ products, continues to be handled by OneLink. Products can be ordered from OneLink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Max Health™ is pleased to announce the advice received from Medsafe, that effective 24/04/2015, Flumazenil injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health™ by Hameln Plus.
Max Health™ is pleased to announce the advice received from Medsafe, that effective 19/03/2015, Neostigmine injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health™ by Hameln Plus.
Max Health™ has been very busy this month hosting visits from our key suppliers from around the globe. Meetings with representatives from Martindale Pharma, Orion Pharmaceuticals and Hameln Plus all went positively, reinforcing our existing strong relationships with our European partners. We thank our partners for making the long trip down to NZ to visit us!
We look forward to bringing more products to the New Zealand market in 2015 and into the future.
Max Health™ has been re-awarded Hospital Supply Status for Ephedrine Injection. The Ephedrine Injection is manufactured by Martindale Pharma in the UK for Max Health in NZ. Ephedrine is now available for purchase.
Distribution of Ephedrine injection and all other Max Health™ products continues to be handled by Onelink. Ephedrine injection can be ordered from Onelink
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Ephedrine Injection details are as follows:
Name: Ephedrine Injection
Strength: 30mg/1ml in 1ml ampoules (10 ampoules)
Onelink Code: PHZ352
Pharmacode: 2402874
Price: POA
Max Health™ has been awarded Hospital Supply Status for Clarithromycin Injection 500mg and will be listed in Section H from January 1st, 2015 and will be available to purchase from 12 December 2014.
The Clarithromycin Powder for Injection is manufactured by Martindale Pharma in the UK for Max Health™ in NZ.
Distribution of Clarithromycin Powder for Injection and all other Max Health™ products is handled by Onelink. Clarithromycin Powder for Injection can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Clarithromycin Powder for Injection details are as follows:
Name: Clarithromycin Powder for Solution in 1ml Vials
Strength: 500mg
Onelink Code: PHAA71
Price: POA
The winner of the NZHPA Max Health™ Pharmacy Grant for 2013, Avril Lee from Waitemata DHB presented an interesting talk at the NZHPA conference on 6th September. The talk – “Building a sustainable interprofessional educational platform to improve medication safety”- described the importance of a pharmacist’s role in engaging young doctors in medication safety and improving their prescribing skills. This innovative initiative was warmly applauded by the packed auditorium. Max Health™ is proud of its commitment to education and development in the Hospital Pharmacy sector, and especially pleased to have supported such a valuable piece of work.
The staff at one of our key suppliers, Hameln Pharma, based in Germany, are understandably delighted with the performance of their national team! Hameln supplies Max Health™ with Dexamethasone Inj, Dobutamine Inj and Alfentanil Inj.
Max Health™has been awarded Hospital Supply Status for Alfentanil Hameln 1mg/2ml Injection and will be listed in Section H from November 1st 2014. This Alfentanil injection is manufactured by Hameln Pharma.
Distribution of Alfentanil Hameln injection and all other Max Health™ products is handled by OneLink. Alfentanil Hamlen injection can be ordered from OneLink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Alfentanil injection details are as follows:
Name: Alfentanil Hameln
Strength: 1 milligram in 2ml ampoules (10 ampoules)
OneLink Code: PHZ 828
Pharmacode:
Price: POA
Max Health™ is delighted to be sponsoring the Pharmacy Technicians Special Interest Meeting on the 15th March 2014 at Waikato Hospital.
The NZHPA Max Health™ Pharmacy Grant for 2013 has been awarded to Avril Lee from Waitemata DHB. The grant recognises innovation in pharmacy practice, problem solving and exceeding customer expectations. Congratulations Avril!
Max Health™ has just been advised by Medsafe that, effective 11 July 2013 the combination injection of Glycopyrronium and Neostigmine (from Martindale) has been registered. This now removes any requirements for Section 29 reporting for this product. We know this will please many of you and we thank you for your co-operation with supplying patient and prescriber names up till now.
Distribution of Glycopyrronium 0.5mg/ml and Neostigmine 2.5mg/ml injection and all other Max Health™ products continues to be handled by OneLink . Products can be ordered from OneLink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Glycopyrronium and Neostigmine injection details are as follows:
Name: Glycopyrronium 0.5mg/ml and Neostigmine 2.5mg/ml injection, 10 x 1ml Amp OneLink Code: PHZ 004
Pharmacode: TBC
Price: POA
Please feel free to contact us for further information.
Max Health™ has been awarded Hospital Supply Status for Glycopyrronium bromide Injection 0.2 mg/ml, 1ml and will be listed in Section H from August 1st 2013 with Sole Supply Status effective from October 1st 2013. This Glycopyrronium injection is manufactured by Martindale Pharma in the UK for Max Health in NZ. Effective immediately Glycopyrronium injection is available for purchase.
Distribution of Glycopyrronium injection and all other Max Health™ products continues to be handled by OneLink . Glycopyrronium injection can be ordered from OneLink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Glycopyrronium injection details are as follows:
Name: Glycopyrronium bromide
Strength: 200 micrograms in 1ml ampoules (10 ampoules)
OneLink Code: PHZ 680
Pharmacode: 2442574
Price: POA
A copy of the pack is attached. Please feel free to contact us for further information.
Max Health™ has been awarded Hospital Supply Status for Magnesium Sulphate Injection 2 mmol/ml, 5ml* and will be listed from December 1st 2012 in both Part II of Section H and Section B of the Pharmaceutical Schedule. This Magnesium Sulphate is manufactured by Martindale Pharma in the UK for Max Health™ in NZ. Effective November 12th Magnesium Sulphate injection is available for purchase.
Distribution of Magnesium Sulphate injection and all other Max Health™ products continues to be handled by OneLink (formerly known as Health Support). Magnesium Sulphate injection can be ordered from OneLink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Magnesium Sulphate details are as follows:
Name: Magnesium Sulphate 10mmol in 5ml*
Strength: 2 mmol/ml, 5ml amps (10s)*
OneLink Code: PHZ 354
Pharmacode: 2406438
Price: POA
* Magnesium Sulphate strength was previously described as 49.3% and will now be described as 2mmol/ml, 5ml or on the pack as 10mmol in 5ml
A copy of the pack is attached. Please feel free to contact us for further information.
Max Health™ has been awarded Sole Supply and Hospital Supply Status for Oxycodone injection 10mg in 1ml (5s) and 20mg in 2ml (5s) and will be listed from October 1st 2012 . This Oxycodone is manufactured by Orion Pharma in Finland for Max Health™ in NZ . Effective immediately Oxycodone injection is available for purchase.
Distribution of Oxycodone injection and all other Max Health™ products continues to be handled by Health Support Ltd. Oxycodone injection can be ordered from HSL on:
0800 70 80 60
0800 266 960
customerservices@healthsupport.co.nz
Phone:
Fax:
E-mail:
Oxycodone details are as follows:
Oxycodone Orion
10mg in 1 ml (5s)
PHZ 346
2405687
POA
Oxycodone Orion
20mg in 2 ml (5s)
PHZ 347
2405695
POA
Name:
Strengths:
Health Support Code:
Pharmacode:
Price:
Name:
Strengths:
Health Support Code:
Pharmacode:
Price:
Copies of the new packs are attached. Please feel free to contact us if you require further information. We look forward to continuing to be of service to Hospital Pharmacy in New Zealand
